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 Abstract 
Three methylated bases, 5-methylcytosine, N4-methylcytosine and N6-methyladenine (m6A), 
can be found in DNA.  However, to date, only 5-methylcytosine has been detected in 
mammalian genomes.  To re-investigate the presence of m6A in mammalian DNA, we used a 
highly sensitive method capable of detecting one N6-methyldeoxyadenosine per million 
nucleosides. Our results suggest that the total mouse genome contains, if any, less than 103 
m6A. Experiments were next performed on PRED28, a putative mammalian N6-DNA 
methyltransferase. The murine PRED28 encodes two alternatively spliced RNA. However, 
although recombinant PRED28 proteins are found in the nucleus, no evidence for an adenine-
methyltransferase activity was detected. 
 
Keywords: adenine methylation; DNA methylation; N6-methyladenine; Down syndrome. 
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 Introduction 
In mammalian DNA, the crucial function of cytosine methylation in chromatin structure and 
gene functions has led to the consideration of 5-methylcytosine (m5C) as the fifth base of 
DNA [1,2]. In addition to m5C, there are two other known methylated bases, N6-
methyladenine (m6A) and N4-methylcytosine (m4C). However, m6A and m4C are generally 
considered to be specific to bacterial or protist DNA [3], and have not yet been identified in 
mammalian DNA. In prokaryotes, the function of m4C and m5C seems to be limited to 
restriction-modification systems [4], although m5C is also part of the very short-patch repair 
system [5]. On the contrary, the biological role of m6A in bacteria is more widespread, and 
includes postreplicative DNA mismatch repair, chromosome compaction and regulation of 
gene expression [4]. Moreover, adenine methylation is essential for the virulence or viability 
of several pathogenic bacterial strains [6-8]. This suggests that bacterial N6-DNA 
methyltransferase is a potential target for the design of new antimicrobial agents [9]. The 
interest for this new generation of antibiotics highlights the necessity for determining the 
existence of N6-DNA methyltransferases in higher eukaryotes.  
The current assumption that m5C is the only methylated base present in animal DNA relies on 
experiments performed about thirty years ago with a detection limit of around 0.01% [10-12]. 
However, even if analytical methods failed to detect m6A in mammalian DNA, indirect 
evidence based on restriction enzyme analyses has suggested the presence of m6A in the 
mouse myogenic and the rat type 2 steroid 5α-reductase genes [13,14]. Hence, current 
analytical methods are sufficient to detect m5C in mammalian DNA (approximately 1-6%), 
but may be inadequate to detect the possible presence of a few hundred m6A in the 3.3x109 
bases of the Homo sapiens genome [15]. This suggests that the methylation status of adenine 
in mammalian DNA could be similar to the situation encountered a few years ago with 
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cytosine methylation in Drosophila melagonaster. Indeed, it had been well-accepted that 
DNA from Drosophila melagonaster was not methylated, a belief recently challenged by  the 
presence of m5C in this species [16]. In this regard, the recent characterization of a N6-
adenine DNA methyltransferase from wheat coleoptiles suggests the occurrence of adenine 
methylation in higher eukaryotes [17].   
A prerequisite for the presence of m6A in mammalian DNA is the expression of a N6-DNA 
methyltransferase. In silico analyses of mouse and human genomes have identified the 
existence of the PRED28 gene that encodes a putative N6-DNA methyltransferase 
(http://harvester.embl.de/harvester/Q9Y5/Q9Y5N5.htm; GenBank gene ID: 29104). This gene 
is located on human chromosome 21 or mouse chromosome 16, two chromosomes syntenic 
for this region. This situation prompted us to re-examine the methylation status of adenine in 
mammalian DNA. 
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Material and Methods. 
 
Bacterial strains. 
E. coli TOP10 (Invitrogen) was used for transformation procedures and maintenance of 
plasmids.  E. coli GM 272 (dam-, dcm-, hsdS-) [18] was used for expression studies. This 
strain has mutations in genes encoding the adenine DNA methyltransferases and is therefore 
expected to have very little m6A in its DNA.   
 
DNA purification and analysis. 
DNA analysis. Genomic DNA was extracted using the Genomic DNA buffer set and Qiagen 
Genomic Tip from Qiagen (Qiagen, Courtaboeuf, France). Human placental mitochondria 
were purified as described [19]. Mitochondrial DNA was extracted using the QIAamp DNA 
kit from Qiagen (Qiagen, Courtaboeuf, France). Subsequently, genomic or mitochondrial 
DNA was incubated with a mixture of endo- and exonucleases, and alkaline phosphatase that 
quantitatively liberate N6-methyldeoxyadenosine (MedAdo) [20]. This was demonstrated 
using plasmid DNA that contained a known amount of MedAdo. A HPLC–electrospray 
ionization tandem mass spectrometry (HPLC–MS/MS) method has been developed for the 
detection of MedAdo, as previously described for the measurement of oxidized nucleosides 
[21,22]. The HPLC–MS/MS system used for the detection of MedAdo has been previously 
described [23]. The limits of sensitivity (S/N=3) for the assay were close to 20 fmol of 
injected MedAdo (corresponding to a concentration of 0.5 nM). Quantification was performed 
by external calibration, and the amount of DNA was determined by UV absorption using the 
peak of deoxyguanosine [22]. 
 
RNA purification and reverse transcription (RT)-PCR. 
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Total RNA extraction and RT-PCR were performed using the Rneasy and Qiagen OneStep 
RT-PCR kits (Qiagen, Courtaboeuf, France). Oligonucleotide primers were designed based on 
the mouse PRED28 cDNA sequence available in the GenBankTM data base under accession 
AY456393. The oligonucleotides used were PRED1a 5’- 
GTGCGTACTCAACGCCCGCCCATAGG-3’ (forward) and PRED1b 5’- 
GCTGCCGGCAGCTCTTGTTTACTTCTGTGG (reverse). Genomic DNA contamination 
was controlled by PCR of non-reverse transcribed RNA. 
 
Cloning of PRED28 splice variants. 
The coding regions of PRED28α and PRED28β were amplified by RT-PCR from embryonic 
mouse brain mRNA and cloned into pcDNA3.1/V5His-TOPO (Invitrogen) to generate 
pcDNA3/PRED28α and pcDNA3/PRED28β. Primers used for PRED28α amplification are 
5’- GCGGAAGGGAAAAGATGGCGGCGCC-3’ (forward) and 5’- 
GAGGGACTTGCTGAACCTGAGGACTGACAGG-3’ (reverse). Primers used for 
PRED28β are 5’- GCGGAAGGGAAAAGATGGCGGCGCC-3’ (forward) and 5’- 
CAATTGTTTTAAAGATTTCCTCTCAG-3’ (reverse). The cDNA sequence of PRED28α 
corresponds to the sequence of the Mus musculus N6-DNA methyltransferase mRNA in 
GenBank under accession AY456393, whereas the cDNA sequence of PRED28β corresponds 
to a new transcript variant deposited under accession AY536887. The full-length coding 
regions of pcDNA3/PRED28α and pcDNA3/PRED28β were amplified with the primers 5’- 
GGGGTACCGAGCTCGGATCCACTAG-3’ (forward) and 5’-
CACGGGGGATCCGCAAACAACAGATGGCTGGCAAC-3’ (reverse) and subcloned in 
the BamHI site of the eukaryotic expression vector pcDNA4/TO (Invitrogen) to generate 
pcDNA4/PRED28α and pcDNA4/PRED28β. To express PRED28 isoforms in E. coli, the 
coding regions of the two isoforms of PRED28 were amplified and cloned under the control 
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of the araBAD promoter in the bacterial expression vector pBAD-TOPO (Invitrogen) to 
generate pBAD/PRED28α and pBAD/PRED28β. The primers used for PRED28α 
amplification were 5’-GCGGCGCCGAGTGTCCCCACGCCG-3’ (forward) and 5’-
GAGGAATAATAAATGGCGGCGCCGAGTGTCCCCACGCCG-3’ (reverse), and the 
primers used for PRED28β are 5’-GCGGCGCCGAGTGTCCCCACGCCG-3’ (forward) and 
5’-TAATAAATGGCGGCGCCGAGTGTCCCCACG-3’ (reverse). All the resulting 
recombinant proteins contain a C-terminal V5 epitope tag and a C-terminal 6 x His tag.  All 
the constructs were verified by DNA sequencing.  
 
Cell culture and transfection.  
C2C12 cells were grown to approximately 80% confluence, and transfection was performed 
by incubating C2C12 cells with either pcDNA4/PRED28α or pcDNA4/PRED28β vector 
using the Lipofectamine 2000™ reagent according to the manufacturer’s instructions 
(Invitrogen). For selection of stable recombinant clones, zeocin (100µg/ml) was added 72 hr 
after transfection. Expression was verified by immunofluorescence staining and western blot 
using a V5 antibody (Invitrogen). 
 
Bacterial expression of recombinant PRED28. 
For the bacterial expression of recombinant proteins, E. coli GM272 clones harboring either 
pBAD/PRED28α or pBAD/PRED28β were grown at 37°C in LB broth containing Amp to an 
O.D.600 of 0.25. At this point the cultures were split, and L-arabinose (0.1% final 
concentration) was added to one of the cultures to induce protein production. After one hour, 
the bacteria were centrifuged and processed for either DNA extraction or for western blot 
analysis. For western blot analysis, cell pellets were resuspended and lysed in CelLytic™ 
buffer (Sigma). Then, cell lysates were centrifugated at 18 000 x g for 15 minutes to pellet the 
in
se
rm
-0
03
90
71
3,
 v
er
sio
n 
1 
- 3
1 
Ju
l 2
00
9
insoluble material. Western blot analyses were performed on both the supernatant and 
insoluble fractions using a V5 antibody (Invitrogen). For DNA analysis, DNA was extracted 
using the DNA genomic buffer set from Qiagen according to the manufacturer’s instructions. 
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 Results 
Determination of m6A content in mammalian and mitochondrial DNA. 
Previous base analyses of mammalian DNA have failed to detect the presence of m6A. 
However, these analyses were performed over twenty years ago with a detection threshold 
around 0.01%. Therefore, in an attempt to re-examine the problem of adenine methylation in 
mammalian DNA, we have developed an extremely sensitive assay for MedAdo with a 
detection threshold of one MedAdo per 106 nucleosides.  However, even using this sensitive 
assay we were unable to detect adenine methylation in the nuclear DNA of several mouse 
tissues (Table 1). According to the size of the mouse genome (2.5 Gb), these results suggest 
that the total mouse genome contains less than 2.5 x 103 m6A. In addition, since it has been 
suggested that mitochondria could be the degenerate descendants of endosymbiotic bacteria, 
and since bacterial DNA is known to contain m6A, mitochondrial DNA from human placenta 
was also included in this study. In contrast to bacterial DNA, which contains MedAdo, no 
MedAdo was detected in mitochondrial DNA (Table 1). 
 
Tissue expression profile of PRED28/N6AM1, a putative N6-DNA methyltransferase. 
The presence of less than 103 m6A in the whole mouse genome could be biologically 
significant if adenine methylation occurs in rare specific gene regulatory elements. However, 
it is difficult to demonstrate the existence of a base which is below the detection limits of 
current analytical methods. This difficulty can be circumvented if we consider that a pre-
requisite for the presence of m6A is the existence of a gene coding for a N6-DNA 
methyltransferase. Analysis of the human and mouse genomes reveals the presence of 
PRED28/N6AM1 on human chromosome 21, or on mouse chromosome 16, which was 
annotated as a putative N6-DNA methyltransferase on the basis of in silico analysis (GenBank 
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accession AY456393). In order to determine the tissue expression profile of PRED28, 
oligonucleotide primers for the mouse PRED28 cDNA sequence deposited in GenBank 
(accession AY456393) were used to amplify PRED28 mRNA. RT-PCR analysis of mRNA 
derived from several mouse tissues demonstrates that the PRED28 gene is expressed in all the 
tissues examined (Fig. 1). Interestingly, two PRED28 isoforms, named PREDα and PREDβ, 
were detected in mouse tissues. The longer PRED28 isoform (PRED28α) is dominant in adult 
tissues. 
 
Cloning and Characterization of PRED28 isoforms. 
To characterize these two mRNAs, molecular cloning and DNA sequencing of the 
corresponding PRED28α and PRED28β cDNA were performed. Nucleotide sequences 
confirm that the PRED28α sequence corresponded to the sequence of the Mus musculus  N6-
DNA methyltransferase mRNA already deposited in GenBank under accession AY456393, 
which encodes for a 23 kDa putative protein (214 amino acids). In contrast, the PRED28β 
sequence corresponded to a new transcript variant that we deposited under accession 
AY536887. Interestingly, this alternative splicing introduces a frame shift that generates a 
stop codon soon after the beginning of exon VI. Thus, PREDβ cDNA encodes a putative 
protein of 14.7 kDa (138 amino acids) (Fig. 2).  
 
Subcellular Localization of PRED28 isoforms. 
To gain insight into the biological function of the PRED28 protein, we analyzed the 
subcellular localization of the two PRED28 isoforms. For this purpose, full-length coding 
sequences corresponding to PRED28α and PRED28β were cloned into the eukaryotic 
expression vector pcDNA4/TO. Then, C2C12 cells were transfected with either 
pcDNA4/PRED28α or pcDNA4/PRED28β. Two stable cell lines expressing either 
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PRED28α (C2C12-Predα) or PRED28β (C2C12-Predβ) were generated.  Results presented in 
Fig. 3 show that recombinant proteins localized mainly in the nucleus. 
 
PRED28 expression in E. coli and C2C12 cells. 
To investigate the ability of PRED28 to methylate adenine residues in DNA, PRED28α and 
PRED28β were expressed in the E. coli GM272 strain. GM272  is a hsdr-, dam-, dcm-  mutant 
[18]. Thus, GM272 DNA contains low levels of m6A and is therefore a useful tool to 
determine if PRED28 production can induce methylation of DNA. DNA fragments encoding 
either PRED28α or PRED28β were placed under the control of the araBAD promoter in the 
vector pBAD-TOPO to generate pBAD/PRED28α or pBAD/PRED28β expression vectors. 
Upon exposure of recombinant GM272 to 0.1% arabinose for 1 hour, immunoblotting of cell 
lysates reveals a protein with a molecular mass corresponding to the PRED28 isoforms (data 
not shown). Analysis of the supernatant and pellet of lysed cells shows that following 
arabinose induction, most of the synthesized protein is found in the soluble fraction (data not 
shown). However, this expression does not increase the basal level of MedAdo found in 
GM272 (Table 1). This residual methyl transferase activity may be due to rare dam+ 
revertants in the cell culture, since this allele reverts at a very low frequency (M. Marinus, 
personal communication). Likewise, no MedAdo can be detected in the genomic DNA of 
mammalian C2C12 cells that are stably transfected with expression vectors encoding either 
PRED28α or PRED28β (Table 1). Therefore, we conclude that under our assays conditions, 
PRED28 has no detectable adenine DNA methyltransferase activity. 
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Discussion 
In order to re-investigate the adenine methylation status of mammalian DNA, we developed 
an extremely sensitive assay for MedAdo detection. Using this assay, which is over 100 times 
more sensitive than previous methods, we were unable to identify adenine methylation in the 
nuclear DNA of several mouse tissues or in human mitochondrial DNA. Hence, if adenine 
methylation occurs, it would only comprise a few hundred adenines. Alternatively, adenine 
methylation could be restricted to a minor population of cells (i.e. stem cells), or may occur 
during a brief period of the cell cycle.  Moreover, it should be noted that the presence of a few 
m6A in DNA may be critical if they are used to control the expression of a small subset of 
transcription factors or miRNAs. In this regard, it is noteworthy that the artificial methylation 
of adenine in several eukaryotic or viral promoters alters their activity [24-27]. Moreover,  the 
addition of MedAdo to cell culture medium has been reported to induce cell differentiation 
[23,28].  
An alternative way to determine the presence of m6A in mammalian genomes is to investigate 
the existence of a N6-DNA methyltransferase in mammalian cells. On the basis of 
bioinformatic analysis, a gene named PRED28, already annotated as coding for a putative N6-
DNA methyltransferase, has been found in murine and human genomes. In humans, two 
mRNA species resulting from the alternative splicing of exon IV have been described 
(NM_013240 and NM_182749) (Fig. 2). Removal of exon IV would be critical for the 
enzymatic activity of the protein since it codes for the NPPY motif characteristic of N6-DNA 
methyltransferases [29] (Fig. 2). This would suggest that the shorter human variant, named 
PREDβ, should be devoid of enzymatic activity. Our results show that in mice, PREDβ is 
generated by removal of exon V instead of exon IV (Fig 2).  Therefore, this alternative 
splicing does not delete the NPPY motif, but results in a frame shift and appearance of a 
premature stop codon in the new reading frame. Hence, the removal of the NPPY site in the 
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human gene and the generation of a frame shift introducing a premature stop codon in the 
mouse gene could represent two alternative methods to generate these isoforms. This could be 
an additional illustration of the role played by molecular tinkering during the course of 
evolution.  
Although devoid of a nuclear localization signal (NLS), both PRED isoforms are 
predominantly localized to the nucleus when expressed in C2C12 cells (Fig. 3). A likely 
explanation for this nuclear localization is the small size of PRED proteins. The estimated 
molecular weights (MW) of PREDα and PREDβ are 23 and 14.7 kDa, respectively. The 
addition of the V5 epitope increases the MW of the fusion proteins by 4.9 kDa. The nuclear 
pore complex (NPC) allows slow diffusion of proteins between 10-20 kDa  [30]. Therefore, 
the nuclear entry of the PRED proteins could be caused by passive diffusion through the NPC.  
Interactions of these two PRED isoforms with nuclear proteins or nucleic acids could limit 
their export from the nucleus. This could explain their preferential localization in the nucleus 
Even though a N6-DNA methyltransferase is predicted to display nuclear localisation,  
expression of PRED28 isoforms in bacteria or in mammalian cells failed to demonstrate any 
adenine DNA methyltransferase activity. A possible explanation for the lack of N6-DNA 
methyltransferase activities of PRED proteins in our methylation assays could be the absence 
of unidentified cofactor(s) required for enzymatic activity. Likewise, the tag used to identify 
the recombinant PRED proteins may interfere with proper activity.  Alternatively, the 
annotation of PRED28 as a putative N6-DNA methyltransferase could have been erroneous. 
Indeed, the NPPY motif characteristic of N6-DNA methyltransferases was recently found to 
be shared by HemK proteins. The HemK protein was initially misidentified and annotated as a 
component of the heme biosynthetic pathway [31]. However, it is now recognized as a 
bacterial N5-glutamine methyltransferase [32]. Therefore, the possibility that PRED28 is an 
uncharacterized mammalian N5-glutamine methyltransferase should be considered. This point 
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warrants further investigation because the human PRED28 gene is localized on chromosome 
21, and it may have a possible contribution to the pathology of Down syndrome. 
On the basis of computer analysis, open reading frames distinct from PRED28 which code for 
several other putative N6-DNA methyltransferases have been detected in eukaryotic genomes 
[33]. This raises the possibility that in higher eukaryotes, proteins other than PRED28 could 
be involved in the methylation of a small number of adenine residues, a point of crucial 
concern if N6-DNA methyltransferase inhibitors are to be used as antibiotics [9,34].  
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Legends to figures. 
 
Fig. 1. RT-PCR analysis of the tissue specific (A) and developmental expression (B) of 
PRED28 in mouse. 
Although both PREDα and β are ubiquitous in all tissues examined, PREDα is expressed at 
higher levels than PREDβ in adult tissues. 
 
 
Fig. 2. Genomic organization and structure of alternatively spliced transcripts of mouse 
and human PRED28. 
The splicing of exon V in the mouse PRED28 results in a frame shift. The two resulting 
alternative amino-acid sequences encoded by the mouse exon VI are shown. GeneBank 
accession numbers are included. 
 
 
Fig. 3. Expression of cloned PRED28α or PRED28β cDNA in C2C12 cells.  
The predominant nuclear location of recombinant PRED28 proteins was demonstrated by 
immunofluorescence staining of C2C12 cells transfected with either pcDNA4/PRED28α or 
pcDNA4/PRED28β expression vectors. The PRED28 isoforms are labelled in green with an 
anti-V5 antibody (Invitrogen) and DNA is labelled in red by propidium iodide.  
 
 
 
 
Table 1. Content of MedAdo in the DNA of different mouse tissues or cells.
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Source of DNA MedAdo/106 nucleosides
heart       < 1
muscle       < 1
liver       < 1
brain       < 1
testis       < 1
brain       < 1
mitochondria       < 1
C2C12       < 1
C2C12-Predα       < 1
C2C12-Predβ       < 1
E. coli  GM272-PREDα non-induced (n = 3) 38.4 ± 10.5
E. coli  GM272-PREDα induced (n = 3) 35.1 ±   9.6
E. coli  GM272-PREDβ non-induced (n = 2) 44.1 ±   3.9
E. coli  GM272-PREDβ induced (n = 3) 35.2 ±   4.2
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